Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for JAZZ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -22.70M
March 31, 2026 -32.90M
December 31, 2025 -85.19M
September 30, 2025 -0.733M
June 30, 2025 114.53M
March 31, 2025 -11.45M
December 31, 2024 -9.196M
September 30, 2024 149.98M
June 30, 2024 150.49M
March 31, 2024 -0.494M
December 31, 2023 90.94M
September 30, 2023 68.86M
June 30, 2023 84.73M
March 31, 2023 -21.23M
December 31, 2022 -30.16M
September 30, 2022 -21.26M
June 30, 2022 -24.82M
March 31, 2022 -21.73M
December 31, 2021 -18.15M
September 30, 2021 -14.82M
June 30, 2021 -51.88M
March 31, 2021 -50.41M
December 31, 2020 -65.34M
September 30, 2020 -10.09M
June 30, 2020 -3.503M
Date Value
March 31, 2020 125.79M
December 31, 2019 78.59M
September 30, 2019 10.03M
June 30, 2019 46.80M
March 31, 2019 108.19M
December 31, 2018 437.38M
September 30, 2018 4.456M
June 30, 2018 -35.46M
March 31, 2018 23.96M
December 31, 2017 33.34M
September 30, 2017 21.84M
June 30, 2017 3.568M
March 31, 2017 8.22M
December 31, 2016 12.25M
September 30, 2016 93.24M
June 30, 2016 18.05M
March 31, 2016 130.58M
December 31, 2015 33.75M
September 30, 2015 2.317M
June 30, 2015 -11.87M
March 31, 2015 -3.166M
December 31, 2014 2.207M
September 30, 2014 -10.32M
June 30, 2014 13.31M
March 31, 2014 -21.47M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc --
Perrigo Co. Plc 0.00
GH Research Plc -111.58M
Cosmo NV --
Axsome Therapeutics, Inc. -55.24M